Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon Inc. stock logo
ALC
Alcon
$86.19
-3.3%
$90.53
$80.48
$101.10
$42.52B0.951.16 million shs1.65 million shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$11.54
-4.5%
$12.81
$5.11
$19.22
$322.99M0.93244,223 shs300,749 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$19.96
-1.6%
$15.18
$5.85
$72.60
$353.73M2.15118,723 shs338,128 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$5.67
-3.4%
$6.54
$4.54
$10.79
$356.59M0.68551,753 shs393,337 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon Inc. stock logo
ALC
Alcon
0.00%-1.96%-1.82%-3.16%-6.57%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
0.00%-17.16%-10.68%-9.84%+103.89%
Outset Medical, Inc. stock logo
OM
Outset Medical
0.00%-4.63%+2.10%+140.63%-71.14%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.00%-2.41%-16.00%-28.68%-6.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alcon Inc. stock logo
ALC
Alcon
3.4605 of 5 stars
3.45.01.70.01.70.81.3
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.5276 of 5 stars
3.54.00.00.01.90.80.6
Outset Medical, Inc. stock logo
OM
Outset Medical
1.9991 of 5 stars
3.53.00.00.02.40.80.0
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.2547 of 5 stars
3.11.00.00.01.84.20.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcon Inc. stock logo
ALC
Alcon
2.80
Moderate Buy$106.1323.12% Upside
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
3.00
Buy$25.00116.64% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
3.00
Buy$27.0035.27% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.29
Hold$10.1679.14% Upside

Current Analyst Ratings Breakdown

Latest ALC, TMCI, CLPT, and OM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2025
Alcon Inc. stock logo
ALC
Alcon
Kepler Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/21/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.00
5/20/2025
Alcon Inc. stock logo
ALC
Alcon
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
5/15/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/14/2025
Alcon Inc. stock logo
ALC
Alcon
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy$102.00 ➝ $99.00
5/14/2025
Alcon Inc. stock logo
ALC
Alcon
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$110.00 ➝ $110.00
5/9/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.60
5/8/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$12.00 ➝ $14.00
4/11/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$9.50 ➝ $8.00
4/1/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$19.00 ➝ $25.00
3/31/2025
Alcon Inc. stock logo
ALC
Alcon
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$108.00 ➝ $112.00
(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcon Inc. stock logo
ALC
Alcon
$9.93B4.28$5.00 per share17.23$41.81 per share2.06
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$32.24M10.02N/AN/A$0.86 per share13.42
Outset Medical, Inc. stock logo
OM
Outset Medical
$115.27M3.07N/AN/A$2.45 per share8.15
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$210.82M1.69N/AN/A$2.24 per share2.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcon Inc. stock logo
ALC
Alcon
$974M$2.2536.8426.202.2911.89%7.17%5.03%8/19/2025 (Estimated)
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$22.09M-$0.76N/AN/AN/A-59.64%-62.10%-38.39%8/6/2025 (Estimated)
Outset Medical, Inc. stock logo
OM
Outset Medical
-$172.80M-$29.15N/AN/A-112.57%-175.64%-38.61%8/6/2025 (Estimated)
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$49.53M-$0.85N/AN/AN/A-30.33%-51.12%-26.36%8/5/2025 (Estimated)

Latest ALC, TMCI, CLPT, and OM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Alcon Inc. stock logo
ALC
Alcon
$0.77$0.73-$0.04$0.70$2.52 billion$2.33 billion
5/13/2025Q1 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.15-$0.22-$0.07-$0.22$8.21 million$8.49 million
5/8/2025Q1 2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.31-$0.25+$0.06-$0.25$52.07 million$52.57 million
5/7/2025Q1 2025
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alcon Inc. stock logo
ALC
Alcon
$0.260.30%N/A11.56%4 Years
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A

Latest ALC, TMCI, CLPT, and OM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/7/2025
Alcon Inc. stock logo
ALC
Alcon
annual$0.32700.3%5/14/20255/14/20255/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcon Inc. stock logo
ALC
Alcon
0.21
2.57
1.60
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/A
4.54
3.61
Outset Medical, Inc. stock logo
OM
Outset Medical
4.12
6.49
5.04
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.51
4.12
2.98

Institutional Ownership

CompanyInstitutional Ownership
Alcon Inc. stock logo
ALC
Alcon
53.86%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%

Insider Ownership

CompanyInsider Ownership
Alcon Inc. stock logo
ALC
Alcon
1.52%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.97%
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
27.72%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alcon Inc. stock logo
ALC
Alcon
25,200493.24 millionN/AOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11027.99 million25.90 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
52017.72 million51.50 millionNot Optionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25062.89 million47.08 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alcon stock logo

Alcon NYSE:ALC

$86.19 -2.93 (-3.28%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$86.06 -0.14 (-0.16%)
As of 06/13/2025 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$11.54 -0.54 (-4.47%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$11.75 +0.21 (+1.82%)
As of 06/13/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Outset Medical stock logo

Outset Medical NASDAQ:OM

$19.96 -0.32 (-1.58%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$19.98 +0.02 (+0.08%)
As of 06/13/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$5.67 -0.20 (-3.41%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$5.68 +0.00 (+0.09%)
As of 06/13/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.